{"title":"An Imperative Need for Further Genetic Studies of Alopecia Areata","authors":"Lynn Petukhova","doi":"10.1016/j.jisp.2020.04.003","DOIUrl":"10.1016/j.jisp.2020.04.003","url":null,"abstract":"<div><p>Human genetic studies of diseases that are multifactorial and prevalent have generated a wealth of knowledge about the genetic architecture of chronic diseases. Generalizable attributes are shaping the development of models to explain how the human genome influences our health and can be leveraged to improve it. Importantly, both rare and common genetic variants contribute to disease risk and provide complementary information. Although initial genetic studies of alopecia areata have yielded insight with high clinical impact, there remains a number of important unanswered questions pertaining to disease biology and patient care that could be addressed by further genetic investigations.</p></div>","PeriodicalId":54791,"journal":{"name":"Journal of Investigative Dermatology Symposium Proceedings","volume":"20 1","pages":"Pages S22-S27"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jisp.2020.04.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38628576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"JAK Inhibitors for the Treatment of Pediatric Alopecia Areata","authors":"Claire E. Hamilton , Brittany G. Craiglow","doi":"10.1016/j.jisp.2020.04.005","DOIUrl":"10.1016/j.jisp.2020.04.005","url":null,"abstract":"<div><p>Alopecia areata is a common autoimmune condition that disproportionately affects children and can significantly hinder quality of life. Few safe and effective therapies are available for the treatment of severely affected pediatric patients. JAK inhibitors have been recently established as an effective and well-tolerated therapy in adults, but there are limited data regarding the use of JAK inhibitors to treat alopecia areata in children. Here, we review the available literature regarding the use of JAK inhibitors in children in dermatology and across other medical disciplines.</p></div>","PeriodicalId":54791,"journal":{"name":"Journal of Investigative Dermatology Symposium Proceedings","volume":"20 1","pages":"Pages S31-S36"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jisp.2020.04.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38628578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Eyebrows Are Important in the Treatment of Alopecia Areata","authors":"Lucy Y. Liu , Brett A. King , Justin M. Ko","doi":"10.1016/j.jisp.2020.04.006","DOIUrl":"10.1016/j.jisp.2020.04.006","url":null,"abstract":"<div><p>Alopecia areata affects not only scalp hair but also other sites of body hair, including eyebrows. Our objective was to investigate the importance of eyebrows in the treatment goals of patients with alopecia areata. Through an online questionnaire, subjects were asked to assess satisfaction with the visually depicted level of response to treatment, using edited photographs depicting a range of eyebrows and scalp hair growth. The questionnaire was completed by 1,741 adults. Absent or partial growth of eyebrows and scalp hair elicited <25% satisfaction. Images depicting either complete eyebrows or complete scalp hair achieved satisfaction in >50% of participants. More participants were satisfied with complete eyebrows and no scalp hair (69%) than complete eyebrows and partial scalp hair (51%). Only when both eyebrows and scalp hair were completely regrown did extreme satisfaction levels reach 90.4%. Limitations include the online nature of the survey, lack of control group, and self-reported severity of alopecia areata in participants. These results suggest that eyebrows may be as important as scalp hair for patients assessing theoretical responses to treatment for alopecia areata. Future clinical studies should consider growth of eyebrows as an outcome measure on par with scalp hair growth.</p></div>","PeriodicalId":54791,"journal":{"name":"Journal of Investigative Dermatology Symposium Proceedings","volume":"20 1","pages":"Pages S37-S40"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jisp.2020.04.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38628579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lourdes M. Perez-Chada , Joseph F. Merola , April W. Armstrong , Amit Garg , John Latella , Alice B. Gottlieb
{"title":"Report from the International Dermatology Outcome Measures Initiative","authors":"Lourdes M. Perez-Chada , Joseph F. Merola , April W. Armstrong , Amit Garg , John Latella , Alice B. Gottlieb","doi":"10.1016/j.jisp.2020.05.004","DOIUrl":"10.1016/j.jisp.2020.05.004","url":null,"abstract":"<div><p>The International Dermatology Outcome Measures is a nonprofit organization dedicated to developing evidence-based, patient-centered outcome measures for dermatologic conditions. At the 2018 Alopecia Areata Research Summit, Dr Gottlieb, President of the International Dermatology Outcome Measures, presented an overview of their work in psoriasis, hidradenitis suppurativa, acne, and eczema and discussed the potential areas of mutual interest with the National Alopecia Areata Foundation. Herein, we present a summary of the topics discussed.</p></div>","PeriodicalId":54791,"journal":{"name":"Journal of Investigative Dermatology Symposium Proceedings","volume":"20 1","pages":"Pages S80-S83"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jisp.2020.05.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38528084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abby Ellison , Dory Kranz , Natasha A. Mesinkovska , Angela M. Christiano , Jerry Shapiro , David A. Norris
{"title":"Forging the Future: 2018 Alopecia Areata Research Summit Summary Report","authors":"Abby Ellison , Dory Kranz , Natasha A. Mesinkovska , Angela M. Christiano , Jerry Shapiro , David A. Norris","doi":"10.1016/j.jisp.2020.05.005","DOIUrl":"10.1016/j.jisp.2020.05.005","url":null,"abstract":"<div><p>Alopecia areata (AA) is a common autoimmune skin disease resulting in the loss of hair on the scalp and elsewhere on the body that affects over 146 million people worldwide at some point in their lives. Founded in 1981, the National AA Foundation (NAAF) is a nonprofit organization that supports research to find a cure or acceptable treatment for AA, supports those with the disease, and educates the public about AA. NAAF conducts research summits every two years to review progress and create new directions in its funded and promoted research. This report from the seventh AA Research Summit, Forging the Future, held December 4–5, 2018 in New York City provides highlights of the research presented and future research priorities identified during targeted discussion sessions.</p></div>","PeriodicalId":54791,"journal":{"name":"Journal of Investigative Dermatology Symposium Proceedings","volume":"20 1","pages":"Pages S1-S5"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1087002420300150/pdfft?md5=9f871657752a74a78026963ab9ca6b87&pid=1-s2.0-S1087002420300150-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38531235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective","authors":"Dustin H. Marks , Maryanne M. Senna","doi":"10.1016/j.jisp.2020.04.008","DOIUrl":"10.1016/j.jisp.2020.04.008","url":null,"abstract":"<div><p>Although alopecia areata (AA) has been traditionally classified as a strictly T helper type 1–mediated process, the T helper type 2 (Th2) pathway may contribute to an AA-like phenotype in some individuals. Herein, we describe three clinical cases that support the potential role of Th2 activity through the upregulation of IL-4 and IL-13 in an AA-like phenotype.</p></div>","PeriodicalId":54791,"journal":{"name":"Journal of Investigative Dermatology Symposium Proceedings","volume":"20 1","pages":"Pages S58-S59"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1087002420300083/pdfft?md5=dd87b629912594b4150b7a6e4ef98fd7&pid=1-s2.0-S1087002420300083-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38528077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Current Treatment of Alopecia Areata","authors":"Maria K. Hordinsky","doi":"10.1016/j.jisp.2020.04.004","DOIUrl":"10.1016/j.jisp.2020.04.004","url":null,"abstract":"<div><p>The number of alopecia areata (AA) clinical trials with Jak inhibitors of cytoplasmic tyrosine kinases, including Jak1, Jak2, Jak3, and tyrosine-protein kinase has increased significantly since the last Research Summit. This fact means that the conversation about current treatments for AA now also needs to include a discussion of traditionally used off-label therapies as well as evolving therapies as with Jak inhibitors.</p></div>","PeriodicalId":54791,"journal":{"name":"Journal of Investigative Dermatology Symposium Proceedings","volume":"20 1","pages":"Pages S28-S30"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1087002420300046/pdfft?md5=6c9e1cfe2e7e9d55ae79970f85c92386&pid=1-s2.0-S1087002420300046-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38628577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Evolving Pathogenesis of Alopecia Areata: Major Open Questions","authors":"Ralf Paus","doi":"10.1016/j.jisp.2020.04.002","DOIUrl":"10.1016/j.jisp.2020.04.002","url":null,"abstract":"","PeriodicalId":54791,"journal":{"name":"Journal of Investigative Dermatology Symposium Proceedings","volume":"20 1","pages":"Pages S6-S10"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jisp.2020.04.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38528078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yunyuan Li , Ruhangiz T. Kilani , Gigi Leung , Aziz Ghahary
{"title":"Myeloid Adherent Cells Are Involved in Hair Loss in the Alopecia Areata Mouse Model","authors":"Yunyuan Li , Ruhangiz T. Kilani , Gigi Leung , Aziz Ghahary","doi":"10.1016/j.jisp.2020.04.001","DOIUrl":"10.1016/j.jisp.2020.04.001","url":null,"abstract":"<div><p>Alopecia areata (AA), which is defined as an autoimmune hair loss disease, has a serious impact on the quality of life for patients with AA worldwide. In this study, to our knowledge, a previously unreported method of AA induction in C3H mice has been established and validated. Using this method, we showed that dermal injection of 1–3 million of a mixture of skin cells freshly isolated from AA-affected skin induces AA in more than 80% of healthy mice. Contrary to the previous protocol, the induction of AA by this approach does not need any surgical AA skin grafting, cell manipulation, or high number of activated T cells. We also showed that dermal injection of adherent myeloid cells (mainly CD11b+) in healthy mice is as potent as a mixture of none adherent CD3+ T cells and CD19+ B cells in the induction of AA. Interestingly, most of the mice (7 out of 8) that received non-adherent cells developed AA universalis, whereas most of the mice (5 out of 7) that received adherent cells developed patchy AA. Finally, we found a high number of stage-specific embryonic antigen-expressing cells whose expression in monocytes in an inflammatory disease causes the release of inflammatory cytokines, TNF-α and IL-1β, from these cells in AA-affected skin.</p></div>","PeriodicalId":54791,"journal":{"name":"Journal of Investigative Dermatology Symposium Proceedings","volume":"20 1","pages":"Pages S16-S21"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1087002420300010/pdfft?md5=1b83db1813c129118f60f01e02b0dbad&pid=1-s2.0-S1087002420300010-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38628575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elizabeth Tkachenko , Kathie P. Huang , Justin M. Ko , Kristina J. Liu , Deborah A. Scott , Maryanne M. Senna , Sara J. Li , Cara J. Joyce , Arash Mostaghimi
{"title":"Brigham Eyebrow Tool for Alopecia: A Reliable Assessment of Eyebrow Alopecia Areata","authors":"Elizabeth Tkachenko , Kathie P. Huang , Justin M. Ko , Kristina J. Liu , Deborah A. Scott , Maryanne M. Senna , Sara J. Li , Cara J. Joyce , Arash Mostaghimi","doi":"10.1016/j.jisp.2020.06.001","DOIUrl":"10.1016/j.jisp.2020.06.001","url":null,"abstract":"<div><p>There are no tools to evaluate eyebrow involvement in patients with alopecia areata. We developed and assessed the reliability of the Brigham Eyebrow Tool for Alopecia (BETA) as a quantitative evaluation of eyebrow alopecia areata. BETA uses facial landmarks of eyebrow anatomy and is calculated using surface area and density. A total of 50 eyebrow images with varying levels of hair loss were distributed to six board-certified dermatologists at three academic medical centers with standardized instructions and examples. Interrater and intrarater reliability were calculated using intraclass correlation coefficients (ICCs). BETA demonstrated high interrater (ICC = 0.88, confidence interval = 0.83–0.92 right eyebrow scores and ICC = 0.90, confidence interval = 0.85–0.94 left eyebrow scores) and intrarater (ICC = 0.90, confidence interval = 0.85–0.93 right eyebrow scores and ICC = 0.91, confidence interval = 0.87–0.94 left eyebrow scores) reliability. When measured in the same patient with varying degrees of hair loss over time, BETA demonstrated sensitivity to change. BETA is a simple and reliable objective assessment of eyebrow alopecia areata. BETA is easy-to-use and quick to calculate, making it feasible for a variety of clinical and research settings. Although developed for alopecia areata, we hope that BETA will be investigated in other etiologies of eyebrow alopecia to serve as a universal tool for monitoring disease progression, improvement, and response to treatment.</p></div>","PeriodicalId":54791,"journal":{"name":"Journal of Investigative Dermatology Symposium Proceedings","volume":"20 1","pages":"Pages S41-S44"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1087002420300198/pdfft?md5=75f793153d7eeaf2960f98addafedd1a&pid=1-s2.0-S1087002420300198-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38628580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}